CD8A and neoplasm: Macrophages in the TME recognize and phagocytose Tregs with high CTLA-4 expression [135, 136], whereas CD8 + effector T cells, with low CTLA-4 expression, remain unaffected [137, 138], further enhancing the efficiency of the anti-tumor immune response (Fig. 2B).